The First International HPV Vaccine Information Clearinghouse
MHRA
Drug Safety Update
Article date: October 2010
Summary
No new risks have been identified for Cervarix despite significant exposure in the UK, and the balance of risks and benefits remains positive. This article summarises the safety experience of the past 2 years.
Time Magazine
Healthland
By Bonnie Rochman Friday, January 7, 2011
Girls really do care what their moms think, even once they’re all grown up. That’s the message that a new study is conveying after researchers found that college-age women are more likely to report getting the human papillomavirus (HPV) vaccine if they’d discussed it with their mothers.
Time Magazine
Healthland
By Meredith Melnick Friday, January 7, 2011
Sexual health specialists have long focused on circumcision as a potential safeguard against acquiring HIV. In fact, a 2006 clinical trial funded by the National Institutes of Health (NIH) found that medical circumcision reduced female-to-male transmission rates by 48% to 60% in two trials in Rakai, Uganda and Kisumu, Kenya.
31 August 2010, France banned advertising Gardasil as an anti-cancer vaccine in their country. Activists from the United Kingdom are battling the same problem with the advertising campaign for GlaxoSmithKline’s HPV vaccine, Cervarix.
FOR IMMEDIATE RELEASE
PRLog (Press Release) – Jan 06, 2011 – It appears false marketing claims are not limited to a single manufacturer and/or distributor of HPV vaccines.
2 February 2010, investigative journalist, Christina England, wrote an article entitled, “Cervarix HPV vaccine adverts are untrue and should be banned.” At the time, she was talking about advertisements plastered on the sides of buses used for transportation along every school route in West Sussex and the route to a local hospital. The advertisements proclaiming Cervarix would ensure you were ‘armed for life’ against cervical cancer were also posted inside the buses and on bathroom doors in local cinemas.
MHRA
January 2011
United Kingdom
The Medicines and Healthcare products Regulatory Agency (MHRA) was set up in April 2003 from a merger of the Medicines Control Agency and the Medical Devices Agency. The MHRA is the government agency which is responsible for ensuring that medicines and medical devices work, and are acceptably safe. The MHRA is an executive agency of the Department of Health.
What are Black Triangle drugs (▼)?
When medicines come onto the market, we have relatively limited information about their safety from clinical trials in the UK. These trials generally involve only small numbers of eligible patients who take the medicine for a relatively short period of time. Therefore, patients in clinical trials may not be fully representative of those who will use the medicine when it is marketed.
